Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Three related series of antitumor tyrosine kinase inhibitors patented by Merck

March 18, 2003

Results from European phase III trial of Plenaxis discussed at EAU meeting

March 17, 2003

Maxim receives NCI SBIR grant for MX-2167

March 17, 2003

NCI grant for trial of NCX-4016 in prevention of colon cancer

March 17, 2003

Novel HDAC inhibitors in Roche development pipeline

March 17, 2003

Bryostatin-1 increases survival in advanced renal cell carcinoma

March 17, 2003

New antiinflammatory IKK-2 inhibitors in early development at AstraZeneca

March 17, 2003

Teva invests in Gamida-Cell

March 14, 2003

OSI to market Novantrone in oncology indications

March 14, 2003

Lorus allowed U.S. patent that protects key antisense target

March 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.